Clever nano-tech takes on Crohn’s
Hungarian and Israeli biotech companies teamed up to tackle Crohn’s, an intractable inflammatory bowel disease that affects five million people worldwide. Its causes are uncertain. There is no foolproof cure and public understanding of the pain and chronic suffering it causes is poor.
Publication date: 17 July 2019